Zepbound results: the weight loss timeline

Month-by-month, based on SURMOUNT-1 trial data

Quick read · 5 min

Last reviewed: April 2026Every claim linked to source

In the SURMOUNT-1 trial, people on tirzepatide 15mg weekly lost an average of 20.9% of their body weight over 72 weeks. For a 230-lb person, that is roughly 48 lbs. The curve is steeper than semaglutide — month 6 on tirzepatide typically matches month 12 on semaglutide. Most people continue losing until month 15 before plateauing.

In simple terms:
  • •Average total loss: 20.9% at 72 weeks on 15mg (the highest tested dose)
  • •10mg dose: ~19.5% average loss
  • •5mg dose: ~15% average loss
  • •First 4 weeks: 3–6 lbs (titration phase)
  • •Months 2–9: the steep part of the curve — most loss happens here
  • •Typical plateau at month 12–15
  • •Roughly 1 in 3 people lose 25% or more (strong responders)

Based on clinical trials · No rankings · Every claim linked to source

The shape of the weight loss curve

Slow start, steep middle, gradual plateau. This is the average curve from SURMOUNT-1 trial.

0%5%10%15%20%25%Start3mo6mo9mo12mo

Source: SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) — 2,539 participants, 72 weeks, tirzepatide 5/10/15mg weekly vs placebo

Milestones: real pounds at each point

Averages from trial data. Individual results vary, but these give you a realistic picture of what to expect.

Time
% of body weight
200 lb person
250 lb person
1 month
~2.5%
~5 lbs
~6 lbs
3 months
~8.5%
~17 lbs
~21 lbs
6 months
~15.5%
~31 lbs
~39 lbs
9 months
~19%
~38 lbs
~47 lbs
12 months
~20.5%
~41 lbs
~51 lbs
18 months
~20.9% (peak)
~42 lbs
~52 lbs

Weights rounded to the nearest pound. Based on starting weights of 200 lb and 250 lb.

The four phases of the year

Knowing where you are in the arc helps you manage expectations — and stops you from panicking when the scale stalls.

1
Weeks 1–8
The slow start
  • •Typical loss: 2–5 lbs
  • •You are still titrating up — the dose is not yet clinically active
  • •Appetite starts to shift, food noise may quieten
  • •Side effects (nausea, fatigue) often peak here
  • •Do not measure success yet
2
Months 2–6
The steep descent
  • •The fastest phase — most of your total loss happens here
  • •You have reached a clinically active dose
  • •Typical loss: 1.5–2.5 lbs per week on average
  • •Scale drops are less linear — some flat weeks are normal
  • •This is when clothes start fitting differently
3
Months 6–12
The slow burn
  • •Loss slows to 0.5–1 lb per week on average
  • •You are chasing the last few percentage points
  • •Resistance training and protein become more important
  • •Small plateaus (1–3 weeks of no movement) are normal
  • •Your maintenance identity starts to form
4
Month 12+
The plateau
  • •Weight stabilises — this is the new set point, not failure
  • •Your body has adapted to a lower energy state
  • •Staying on treatment keeps the weight off
  • •Stopping typically means regaining 50–70% within a year
  • •Long-term: most people maintain their loss on-drug

The first month: managing expectations

Why the first few weeks feel like nothing

You are on the starting dose. That dose is not designed to cause weight loss — it is designed to let your gut adapt to the drug so you do not vomit for a week straight. Weight loss really begins when you reach the first clinically active dose, which is 4–12 weeks in depending on the drug.

The scale may still move 2–5 lbs in the first month, mostly from appetite reduction and water weight. That is normal and expected. The steep part of the curve comes later.

Not everyone gets the average

Trial averages hide a wide range. Here is how participants were distributed at 68–72 weeks.

~36%
Strong responders

lost 25% or more

~91%
Average responders

lost 5% or more

~83%
Modest responders

lost 10% or more

Percentages overlap — a "10% responder" is also counted in the "5% responder" group.

Hitting the plateau

Plateauing is not the same as failing
When you stop losing weight around month 12, the drug has not stopped working. Your body has adapted. At lower body weight, you burn fewer calories at rest — a 200-lb body does not need the same fuel as a 250-lb body. The plateau is where the drug's appetite suppression now matches your new maintenance needs. If staying on treatment keeps you at your new weight, that is success, not failure.

Keep reading

Full Tirzepatide overview →Dosage guide →Titration schedule →Side effects →What happens if you stop →Compare results head-to-head →

Based on clinical trials · No rankings · Every claim linked to source

Last reviewed: March 2026

Medical disclaimer: This website is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment.